−250 KRW
48.36 B KRW
68.87 B KRW
15.25 M
About L&C BIO
Sector
Industry
CEO
Hwan-Chul Lee
Website
Headquarters
Seongnam
Founded
2011
ISIN
KR7290650001
FIGI
BBG00LX74Q18
L&C BIO Co., Ltd. develops soft tissue, allografts, and medical devices. Its products include allograft materials, medical equipment, and functional cosmetics. The company was founded on August 1, 2011 and is headquartered in Seongnam-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 290650 is 22,500 KRW — it has increased by 1.58% in the past 24 hours. Watch L&C BIO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange L&C BIO stocks are traded under the ticker 290650.
290650 stock has risen by 5.88% compared to the previous week, the month change is a 39.75% rise, over the last year L&C BIO has showed a −22.28% decrease.
290650 reached its all-time high on Oct 6, 2020 with the price of 51,850 KRW, and its all-time low was 5,000 KRW and was reached on Aug 6, 2019. View more price dynamics on 290650 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
290650 stock is 7.86% volatile and has beta coefficient of 0.83. Track L&C BIO stock price on the chart and check out the list of the most volatile stocks — is L&C BIO there?
Today L&C BIO has the market capitalization of 510.41 B, it has increased by 0.45% over the last week.
Yes, you can track L&C BIO financials in yearly and quarterly reports right on TradingView.
290650 net income for the last quarter is −5.17 B KRW, while the quarter before that showed 1.06 B KRW of net income which accounts for −585.60% change. Track more L&C BIO financial stats to get the full picture.
Yes, 290650 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 0.44%. Tracking L&C BIO dividends might help you take more informed decisions.
L&C BIO dividend yield was 0.34% in 2023, and payout ratio reached 4.69%. The year before the numbers were 0.22% and 24.96% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 123.00 employees. See our rating of the largest employees — is L&C BIO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. L&C BIO EBITDA is 10.28 B KRW, and current EBITDA margin is 20.41%. See more stats in L&C BIO financial statements.
Like other stocks, 290650 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade L&C BIO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So L&C BIO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating L&C BIO stock shows the sell signal. See more of L&C BIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.